ATMP Service Providers Market Size, Share & Trends Analysis Report By Type Of Service (Analytics, Quality, CMO, Logistics), By Application (GTMP, sCTMP, TEP), Region And Segment Forecasts, 2025-2034
ATMP Service Providers Market Size is valued at 16.68 Billion in 2024 and is predicted to reach 42.57 Billion by the year 2034 at a 9.9% CAGR during the forecast period of 2025-2034.

Advanced Therapy Medicinal Products (ATMPs) are therapies for human consumption with an active therapeutic substance that may be based on the technology to modify a patient's genome, recombinant nucleic acids or genes, engineered tissue and substantially manipulated cells or cells intended for a different essential function in the patient versus the donor. They offer groundbreaking new opportunities to treat life-threatening diseases where one or limited doses have a curative effect. In the case of gene-based ATMPs, recombinant genes are generated in the lab by combining several DNA from different sources to treat genetic abnormalities, cancer, or long-term diseases. In cell-based therapies, cells are modified to change their biological properties or cells or tissues that are not meant for the same vital roles in the body. They are capable of curing, diagnosing, and preventing diseases. Tissue-engineered therapies of ATMP have cells or tissues that have been modified to be used to repair, regenerate or replace human tissue. ATMP services include analysis of active therapeutic substances, documentation, standards and regulations in GMP, and logistics like storage and transportation.
Increasing demand for personalized medication pushes the technology towards advancements in biological therapeutics, leading to innovative Advanced Therapy Medicinal Products, which is the crucial factor for ATMP service providers' market growth. Extensive research activities, rising approvals for new drug products, stakeholders' investments in clinical trials and Large pipeline products will boost the service providers' market. The COVID-19 outbreak has adversely affected the overall medical industry, but the pandemic enabled the operations and development of advanced therapeutics. In Feb 2022, Takara Bio, Inc expanded the GMP facility to accommodate a variety of modalities and strengthen the supply chain. The facility's expansion, which went into operation in 2020, increased production capacity.
Lack of production capabilities and cost of services regarding ATMP production are significant factors affecting the progress of the ATMP services providers market. The availability of a significant number of FDA-approved advanced therapy medicinal products in the United States has gained a substantial share of revenue in the North America region.
Market Segmentation
Global ATMP Service Providers market is segmented into by type services and by applications. Type of services comprises analytics, quality, CMO, logistics. The subsegment analytics covers Microbiology, Endotoxin, PCR, Flow Cytometry, ELISA, Container Closure, Sterilty, and Pre-clinical. Quality subegment has documentation, QMS and regulations. Whereas, CMO includes HQ/GMP plasmid DNA, MSC manufacture, Pluripotent stem cells. In logistics, storage, stability and transport are subdivisions. CMO will contribute the largest share of the revenue in the coming years in the ATMP service providers market. Secondly, the segmentation by application contains GTMP(Gene Therapy Medicinal Products), sCTMP(somatic Cells Therapy Medicinal Products) and TEP(Tissue Engineered Products).
Competitive Landscape
Some of The Key Players in The ATMP Service Providers Market:
- Takara Bio
- NorthX Biologics
- Cellco Labs
- AWA
- ClinStorage
- Key2Complience
- Nordic BioAnalysis
- YSDS
- Truly Labs
- ABC Labs
- Mikrolabs
- NDA group
- Propharma group
- Celonic
- Bio Elpida
- CGT Catapult
- Rentschler Biopharma SE
- AGC Biologics
- WuXi Advanced Therapies
- BlueReg, Minaris Regenerative Medicine
- Patheon
- Bio-Techne Corporation
- bioMérieux SA
- Catalent, Inc.
- Charles River Laboratories International Inc.,
- Eurofins Scientific SE
- Hoffmann-La Roche Ltd
- Intertek Group plc
- Lonza Group AG
- Merck KGaA
- Sartorius AG
- SGS S.A.
- Sistemic Scotland Limited
- Thermo Fisher Scientific Inc.
- Vigene Biosciences, Inc.
- WuXi AppTec
- Other Prominent Players
The ATMP Service Providers Market Report Scope
| Report Attribute | Specifications |
| Market Size Value In 2024 | USD 16.68 Billion |
| Revenue Forecast In 2034 | USD 42.57 Billion |
| Growth Rate CAGR | CAGR of 9.9% from 2025 to 2034 |
| Quantitative Units | Representation of revenue in US$ Million and CAGR from 2023 to 2031 |
| Historic Year | 2021 to 2024 |
| Forecast Year | 2025-2034 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Type of Service, By Application |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; South Korea; South East Asia |
| Competitive Landscape | Takara Bio, NorthX Biologics, Cellco Labs, AWA, ClinStorage, Key2Complience, Nordic BioAnalysis, YSDS, Truly Labs, ABC Labs, Mikrolabs, NDA group, Propharma group, Celonic, Bio Elpida, CGT Catapult, Rentschler Biopharma SE, AGC Biologics, Catalent, WuXi Advanced Therapies, BlueReg, Minaris Regenerative Medicine, Patheon, Bio-Techne Corporation, bioMérieux SA, Catalent, Inc., Charles River Laboratories International Inc., Eurofins Scientific SE, F. Hoffmann-La Roche Ltd, Intertek Group plc, Lonza Group AG, Merck KGaA, Sartorius AG, SGS S.A., Sistemic Scotland Limited, Thermo Fisher Scientific Inc., Vigene Biosciences, Inc., WuXi AppTec and others |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing and Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Segmentation of ATMP Service Providers Market
Global ATMP Service Providers Market, by Type of Service, 2024-2034 (Value US$ Mn)
- Analytics/CRO
- Microbioilogy
- Endotoxin
- PCR
- Flow Cytometry
- ELISA
- Container Closure
- Sterility
- Pre-clinical
- Quality
- Documentation
- QMS
- Regulations
- CMO
- HQ/GMP Plasmid DNA
- MSC Manufacture
- Pluripotent Stem Cells
- Logistics
- Storage
- Stability
- Transport
Global ATMP Service Providers Market, by Application, 2024-2034 (Value US$ Mn)
- GTMP
- sCTMP
- TEP
Global ATMP Service Providers Market, by Region, 2024-2034 (Value US$ Mn)
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
North America ATMP Service Providers Market, by Country, 2024-2034 (Value US$ Mn)
- U.S.
- Canada
Europe ATMP Service Providers Market, by Country, 2024-2034 (Value US$ Mn)
- Germany
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific ATMP Service Providers Market, by Country, 2024-2034 (Value US$ Mn)
- India
- China
- Japan
- South Korea
- Australia & New Zealand
Latin America ATMP Service Providers Market, by Country, 2024-2034 (Value US$ Mn)
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa ATMP Service Providers Market, by Country, 2024-2034 (Value US$ Mn)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
ATMP Service Providers Market Size is valued at 16.68 Billion in 2024 and is predicted to reach 42.57 Billion by the year 2034
ATMP Service Providers Market is expected to grow at a 9.9% CAGR during the forecast period for 2025-2034.
Takara Bio, NorthX Biologics, Cellco Labs, AWA, ClinStorage, Key2Complience, Nordic BioAnalysis, YSDS, Truly Labs, ABC Labs, Mikrolabs, NDA group, Pro
Type of Service and Application are the key segments of the ATMP Service Providers Market.
North American region is leading the ATMP Service Providers XX Market.